{"transactions":[{"id":2529599,"issuer":{"id":47614,"kind":"organization","name":"Udemy, Inc.","symbol":"UDMY"},"owners":[{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":1,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":5,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D  Convertible Preferred Stock","published_at":"2021-11-02T19:00:27.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":1418858,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Norwest Venture Partners XII, LP. Genesis VC Partners XII, LLC is the general partner of Norwest Venture Partners XII, LP, and NVP Associates, LLC is the managing member of Genesis VC Partners XII, LLC. Each of Promod Haque, Jeffrey Crowe, and Jon Kossow, who are co-chief executive officers of NVP Associates, LLC, may be deemed to share voting and dispositive power over the shares held by Norwest Venture Partners XII, LP. Each of the reporting entities and individuals disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1418858},"source":{"system":"sec-edgar","filing":"0000899243-21-042450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000089924321042450/doc4.xml","form_type":"4"}},{"id":2529598,"issuer":{"id":47614,"kind":"organization","name":"Udemy, Inc.","symbol":"UDMY"},"owners":[{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":1,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":5,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2021-11-02T19:00:27.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":10134082,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Norwest Venture Partners XII, LP. Genesis VC Partners XII, LLC is the general partner of Norwest Venture Partners XII, LP, and NVP Associates, LLC is the managing member of Genesis VC Partners XII, LLC. Each of Promod Haque, Jeffrey Crowe, and Jon Kossow, who are co-chief executive officers of NVP Associates, LLC, may be deemed to share voting and dispositive power over the shares held by Norwest Venture Partners XII, LP. Each of the reporting entities and individuals disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10134082},"source":{"system":"sec-edgar","filing":"0000899243-21-042450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000089924321042450/doc4.xml","form_type":"4"}},{"id":2529597,"issuer":{"id":47614,"kind":"organization","name":"Udemy, Inc.","symbol":"UDMY"},"owners":[{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":1,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":5,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T19:00:27.000Z","date":"2021-11-02","kind":"exercise","acquired":true,"shares":11552940,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Norwest Venture Partners XII, LP. Genesis VC Partners XII, LLC is the general partner of Norwest Venture Partners XII, LP, and NVP Associates, LLC is the managing member of Genesis VC Partners XII, LLC. Each of Promod Haque, Jeffrey Crowe, and Jon Kossow, who are co-chief executive officers of NVP Associates, LLC, may be deemed to share voting and dispositive power over the shares held by Norwest Venture Partners XII, LP. Each of the reporting entities and individuals disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":12458934,"source":{"system":"sec-edgar","filing":"0000899243-21-042450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000089924321042450/doc4.xml","form_type":"4"}},{"id":3080135,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-17T18:00:27.000Z","date":"2020-07-15","kind":"other","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XII, LP (\"NVP XII\") to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XII, LP (\"NVP XII\") to its limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities shown on Line 2 of Table I represent securities held of record by NVP XII. Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":1752090,"source":{"system":"sec-edgar","filing":"0001209191-20-042940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919120042940/doc4.xml","form_type":"4"}},{"id":3080134,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-17T18:00:27.000Z","date":"2020-07-15","kind":"other","acquired":false,"shares":599939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XI, LP (\"NVP XI\") to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XI, LP (\"NVP XI\") to its limited partners."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The NVP XI distribution resulted in a change in the form of beneficial ownership so that following the distribution 123 shares were beneficially owned by Kossow Family Trust, of which Mr. Kossow is a Trustee. The remaining 1,752,091 shares are held of record by NVP XI. Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":1752214,"source":{"system":"sec-edgar","filing":"0001209191-20-042940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919120042940/doc4.xml","form_type":"4"}},{"id":3303775,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-23T17:30:44.000Z","date":"2020-01-21","kind":"other","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XII, LP (\"NVP XII\") to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XII, LP (\"NVP XII\") to its limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities shown on Line 2 of Table I represent securities held of record by NVP XII. Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":2352090,"source":{"system":"sec-edgar","filing":"0001209191-20-004714","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919120004714/doc4.xml","form_type":"4"}},{"id":3303774,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-23T17:30:44.000Z","date":"2020-01-21","kind":"other","acquired":false,"shares":599938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XI, LP (\"NVP XI\") to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XI, LP (\"NVP XI\") to its limited partners."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The NVP XI distribution resulted in a change in the form of beneficial ownership so that following the distribution 62 shares were beneficially owned by Kossow Family Trust, of which Mr. Kossow is a Trustee. The remaining 2,352,091 shares are held of record by NVP XI. Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":2352153,"source":{"system":"sec-edgar","filing":"0001209191-20-004714","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919120004714/doc4.xml","form_type":"4"}},{"id":3454151,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":35919,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":35919},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454150,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":424568,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":424568},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454149,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":471831,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":471831},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454148,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":577045,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":577045},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454147,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":1442727,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1442727},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454146,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":35919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":35919},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454145,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":424568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":424568},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454144,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":471832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":471832},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454143,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":577045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":577045},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454142,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":1442727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1442727},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454141,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":2952090,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":2952090,"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454140,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":2952091,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":2952091,"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":4326969,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":165565,"kind":"person","name":"Howard Matthew D.","position":3,"cik":"0001576176","reported_name":"Howard Matthew D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":4,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":5,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-10T17:47:54.000Z","date":"2017-05-08","kind":"other","acquired":false,"shares":900000,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were disposed via a pro rata in-kind distribution of Issuer's common stock from Norwest Venture Partners XII, LP (\"NVP XII\") to its limited and general partners."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares were disposed via a pro rata in-kind distribution of Issuer's common stock from Norwest Venture Partners XII, LP (\"NVP XII\") to its limited and general partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities shown on Line 2 of Table I represent securities held of record by NVP XII. By virtue of their positions as co-Chief Executive Officers of NVP Associates, the managing member of the general partner of NVP XII, Promod Haque, Jeffrey Crowe and Matthew D. Howard may be deemed to share voting and dispositive power with respect to such securities. Messers. Haque, Crowe and Howard disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":284747,"source":{"system":"sec-edgar","filing":"0001209191-17-031386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919117031386/doc4.xml","form_type":"4"}},{"id":4326968,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":165565,"kind":"person","name":"Howard Matthew D.","position":3,"cik":"0001576176","reported_name":"Howard Matthew D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":4,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":5,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-10T17:47:54.000Z","date":"2017-05-08","kind":"other","acquired":false,"shares":900000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). By virtue of their positions as co-Chief Executive Officers of NVP Associates, LLC (\"NVP Associates\"), the managing member of the general partner of NVP XI, Promod Haque, Jeffrey Crowe and Matthew D. Howard may be deemed to share voting and dispositive power with respect to such securities. Messrs. Haque, Crowe and Howard disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were disposed via a pro rata in-kind distribution of Issuer's common stock from NVP XI to its limited and general partners."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were disposed via a pro rata in-kind distribution of Issuer's common stock from NVP XI to its limited and general partners."}],"balance_after":284747,"source":{"system":"sec-edgar","filing":"0001209191-17-031386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919117031386/doc4.xml","form_type":"4"}},{"id":4575117,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":165565,"kind":"person","name":"Howard Matthew D.","position":3,"cik":"0001576176","reported_name":"Howard Matthew D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":4,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":5,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2016-10-25T19:54:51.000Z","date":"2016-10-25","kind":"exercise","acquired":false,"shares":397883,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The securities shown on Line 2 of Table I and Lines 3 and 4 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). By virtue of their positions as co-Chief Executive Officers of NVP Associates, LLC(\"NVP Associates\"), the managing member of the general partner of NVP XII, Promod Haque, Jeffrey Crowe and Matthew D. Howard may be deemed to share voting and dispositive power with respect to such securities. Messers. Haque, Crowe and Howard disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":397883},"source":{"system":"sec-edgar","filing":"0001209191-16-146911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919116146911/doc4.xml","form_type":"4"}},{"id":4575116,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":165565,"kind":"person","name":"Howard Matthew D.","position":3,"cik":"0001576176","reported_name":"Howard Matthew D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":4,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":5,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2016-10-25T19:54:51.000Z","date":"2016-10-25","kind":"exercise","acquired":false,"shares":786864,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The securities shown on Line 2 of Table I and Lines 3 and 4 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). By virtue of their positions as co-Chief Executive Officers of NVP Associates, LLC(\"NVP Associates\"), the managing member of the general partner of NVP XII, Promod Haque, Jeffrey Crowe and Matthew D. Howard may be deemed to share voting and dispositive power with respect to such securities. Messers. Haque, Crowe and Howard disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":786864},"source":{"system":"sec-edgar","filing":"0001209191-16-146911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919116146911/doc4.xml","form_type":"4"}},{"id":4575115,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":165565,"kind":"person","name":"Howard Matthew D.","position":3,"cik":"0001576176","reported_name":"Howard Matthew D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":4,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":5,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2016-10-25T19:54:51.000Z","date":"2016-10-25","kind":"exercise","acquired":false,"shares":397883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). By virtue of their positions as co-Chief Executive Officers of NVP Associates, LLC(\"NVP Associates\"), the managing member of the general partner of NVP XI, Promod Haque, Jeffrey Crowe and Matthew D. Howard may be deemed to share voting and dispositive power with respect to such securities. Messrs. Haque, Crowe and Howard disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series E Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series E Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series E Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":397883},"source":{"system":"sec-edgar","filing":"0001209191-16-146911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919116146911/doc4.xml","form_type":"4"}},{"id":4575114,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":165565,"kind":"person","name":"Howard Matthew D.","position":3,"cik":"0001576176","reported_name":"Howard Matthew D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":4,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":5,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2016-10-25T19:54:51.000Z","date":"2016-10-25","kind":"exercise","acquired":false,"shares":786864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). By virtue of their positions as co-Chief Executive Officers of NVP Associates, LLC(\"NVP Associates\"), the managing member of the general partner of NVP XI, Promod Haque, Jeffrey Crowe and Matthew D. Howard may be deemed to share voting and dispositive power with respect to such securities. Messrs. Haque, Crowe and Howard disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series D Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series D Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series D Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":786864},"source":{"system":"sec-edgar","filing":"0001209191-16-146911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919116146911/doc4.xml","form_type":"4"}},{"id":4575113,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":165565,"kind":"person","name":"Howard Matthew D.","position":3,"cik":"0001576176","reported_name":"Howard Matthew D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":4,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":5,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-25T19:54:51.000Z","date":"2016-10-25","kind":"exercise","acquired":true,"shares":1184747,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The securities shown on Line 2 of Table I and Lines 3 and 4 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). By virtue of their positions as co-Chief Executive Officers of NVP Associates, LLC(\"NVP Associates\"), the managing member of the general partner of NVP XII, Promod Haque, Jeffrey Crowe and Matthew D. Howard may be deemed to share voting and dispositive power with respect to such securities. Messers. Haque, Crowe and Howard disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":1184747,"source":{"system":"sec-edgar","filing":"0001209191-16-146911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919116146911/doc4.xml","form_type":"4"}},{"id":4575112,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":165565,"kind":"person","name":"Howard Matthew D.","position":3,"cik":"0001576176","reported_name":"Howard Matthew D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":4,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":5,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-25T19:54:51.000Z","date":"2016-10-25","kind":"exercise","acquired":true,"shares":1184747,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). By virtue of their positions as co-Chief Executive Officers of NVP Associates, LLC(\"NVP Associates\"), the managing member of the general partner of NVP XI, Promod Haque, Jeffrey Crowe and Matthew D. Howard may be deemed to share voting and dispositive power with respect to such securities. Messrs. Haque, Crowe and Howard disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series D Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series E Convertible Preferred Stock automatically converted into common stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date."}],"balance_after":1184747,"source":{"system":"sec-edgar","filing":"0001209191-16-146911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919116146911/doc4.xml","form_type":"4"}}]}